Jonathan Barratt and Richard Lafayette on Evolving Treatments in IgAN: Listen to the Podcast!
Join Jonathan Barratt (UK) and Richard Lafayette (US) as they explore the challenges of treating patients with IgA nephropathy (IgAN), especially younger individuals.
With new medications now available, navigating treatment options has become more complex. Professor Lafayette presents a compelling case study from his practice, highlighting the real-world challenges of managing IgAN.
This podcast is supported by Vera Therapeutics.
